Back to results
RecruitingPhase 4

Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer

NCT05183828

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, United States

Contact

Meghan R. Flanagan

206-667-6736mrf22@uw.edu
View on ClinicalTrials.gov
Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer — TrialFind